People News

Share this article:

Oriel Therapeutics, a specialty pharma concentrated on respiratory care, has appointed Richard Fuller as CEO, effective immediately. Fuller was formerly a senior executive at GlaxoSmithKline, and was most recently executive vice president of research and development at Aerovance.

 
TheraGenetics Limited, a personalized medicine diagnostics company, has appointed Robert McBurney to executive vice president.  McBurney will report to Richard Kivel, CEO of TheraGenetics.

 
Curemark, a biotech focused on the treatment of neurological and other diseases, has appointed Elisa Zinberg as vice president of operations. Zinberg was previously COO of The Masters Circle, a health care consulting company.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.